Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2

By afschroeder • September 27, 2025

Grinspoon SK, Zhao S, Martinez E, Fichtenbaum CJ, Chu SM, Diggs MR, Umbleja T, McCallum S, Fitch KV, Triant VA, Currier JS, Aberg JA, Malvestutto CD, Erlandson KM, Bloomfield GS, Lu MT, Douglas PS, Ribaudo HJ, Zanni MV. Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2. Clin Infect Dis. 2025 Sep 26:ciaf542. doi: 10.1093/cid/ciaf542. Epub ahead of print. PMID: 41004413.

Tags: atherosclerotic cardiovascular disease, HIV, Infectious Diseases, Publications, REPRIEVE, risk scores, statin

Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification

Gu Y, Ibrahim BA, Gebremariam T, Alkhazraji S, Aerts R, Vanbiervliet Y, Lagrou K, Maertens J, Prattes J, Egger M, Dichtl K, Jenks JD, Hoenigl[...]

Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against Bacteria and Fungi

Lohan S, Tiwari RK, Maslennikov I, Das Gupta K, Singh S, Parang K. Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against[...]

Bloodstream Infections Among Veterans With Cardiac Implantable Electronic Devices: Source Identification and Intervention Strategies

Basnet D, Golenbock S, Strymish JM, Mull HJ, Lamkin RP, Shin M, Harvey K, Karchmer AW, Branch-Elliman W. Bloodstream Infections Among Veterans With Cardiac Implantable[...]